Enrollment Completed in First Clinical Trial of Scanadu Scout

STSI is first to study the Qualcomm Tricorder XPRIZE Finalist


News Release

Scanadu ScoutResearchers with the Scripps Translational Science Institute (STSI) have completed enrollment in the first clinical trial of the Scanadu Scout™, a wireless health sensor that measures four vital signs in a few seconds by touching the device to the temple.

“As more wireless health sensors become available to consumers, it is critical that these technologies undergo independent, scientific testing to validate their effectiveness and value,” said Eric Topol, MD, who directs STSI and serves as chief academic officer of Scripps Health. “This study fully reflects the institute’s mission of clinical validation of promising digital technology before it goes into mainstream medicine.”

Read full news release via Scripps Health.

View summary of news coverage via Scripps Health.